Fig. 4From: Impact of renin–angiotensin–aldosterone-system inhibitor drugs on mortality in patients with atrial fibrillation and hypertensionSubgroup analysis for associations between ACEI/ARB therapy and one-year all-cause mortality in patients with AF and hypertensionBack to article page